Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Korean J Ophthalmol ; 23(3): 188-92, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19794946

RESUMO

PURPOSE: To study the concentration of vascular endothelial growth factor (VEGF) in the aqueous humor before and after intracameral injection of bevacizumab in eyes with neovascular glaucoma, and to detect the duration of an anti-VEGF effect of bevacizumab in the anterior chamber. METHODS: In this prospective interventional case series, 1.25 mg of bevacizumab was injected into the anterior chamber of five eyes in five neovascular glaucoma patients. Aqueous humor samples were obtained just before intracameral injection of bevacizumab and two weeks after injection. The concentrations of VEGF in the aqueous humor were measured using ELISA. To investigate corneal endothelial damage after intrecameral bevacizumab injection, specular microscopy was performed before injection and two weeks after injection. Slit lamp photo and iris fluorescent angiography was performed to determine the regression of iris neovascularization. RESULTS: After injection, substantial regression of neovascularization or fluorescein leakage was seen in all treated eyes. The VEGF concentrations in the aqueous humor in eyes with NVG were 1181.8 + or - 1248.3 pg/mL before intracameral injection of bevacizumab. Two weeks after injection, the VEGF concentrations decreased to 33.2 + or - 12.2 pg/mL (p=0.04, Wilcoxon signed rank test). There were no significant changes in IOP or corneal endothelial cells. CONCLUSIONS: Intracameral bevacizumab injection can remarkably reduce iris neovascularization in neovascular glaucoma patients. VEGF levels were significantly decreased two weeks after injection and corneal toxicity was not observed during short term follow-up.


Assuntos
Inibidores da Angiogênese/administração & dosagem , Anticorpos Monoclonais/administração & dosagem , Humor Aquoso/metabolismo , Glaucoma Neovascular/tratamento farmacológico , Glaucoma Neovascular/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Monoclonais Humanizados , Bevacizumab , Olho , Humanos , Injeções , Pessoa de Meia-Idade , Concentração Osmolar , Estudos Prospectivos , Fator A de Crescimento do Endotélio Vascular/antagonistas & inibidores
2.
Korean J Ophthalmol ; 21(2): 124-6, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17592245

RESUMO

PURPOSE: To report a case of bilateral spontaneous anterior lens dislocation associated with retinitis pigmentosa (RP). METHODS: A 45-year-old male with RP presented with elevated intraocular pressure (IOP) in the right eye and was treated with laser iridotomy (LI). After LI, complete crystalline lens dislocation into the anterior chamber occurred. Surgical intervention, including anterior vitrectomy, intracapsular cataract extraction (ICCE), and IOL scleral fixation was performed. Two years later, the same episode occurred in his left eye and a similar treatment was done. RESULTS: Surgery was successful in both eyes. CONCLUSIONS: This is the first report of bilateral spontaneous anterior lens dislocation in a RP patient.


Assuntos
Câmara Anterior , Subluxação do Cristalino/etiologia , Retinose Pigmentar/complicações , Catarata/complicações , Catarata/diagnóstico , Extração de Catarata , Eletrorretinografia , Seguimentos , Humanos , Iris/cirurgia , Terapia a Laser/efeitos adversos , Implante de Lente Intraocular/métodos , Subluxação do Cristalino/diagnóstico , Subluxação do Cristalino/cirurgia , Masculino , Pessoa de Meia-Idade , Hipertensão Ocular/complicações , Hipertensão Ocular/fisiopatologia , Hipertensão Ocular/cirurgia , Retinose Pigmentar/diagnóstico , Retinose Pigmentar/cirurgia , Esclera/cirurgia , Técnicas de Sutura , Campos Visuais , Vitrectomia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...